Efficacy or effectiveness?
December 9, 2008Research and Development Les Rose, clinical trials, evidence
The question of ‘generalisability’ – or the extent clinical trials can be applied to the real world, has been an …
Caution: you are entering phase III
December 8, 2008Research and Development clinical trials, drug development, phase III
Patient: "I've just gone into phase III! What are my chances of coming through alive?" Doctor: "Well the prognosis is …
Cytotoxic therapies to feel sting of generics
December 8, 2008Sales and Marketing generics
Cytotoxic therapy has been the cornerstone of cancer treatment for many years: indeed, despite a number of unpleasant side effects, …
SMC criticises PPRS prescribing incentives
December 5, 2008Sales and Marketing NICE, par
The government move to incentivise doctors for the prescription of new innovative medicines has been criticised by the Scottish Medicines …
Rawlins could stay on at NICE
December 4, 2008NICE
Prof Sir Michael Rawlins could be set to extend his tenure as chairman of NICE, with the government prepared to …
New Pegasys licence gives patients ‘second chance for a cure’
December 4, 2008Sales and Marketing Roche, hepatitis
Hepatitis C patients who don't at first respond to treatment with Pegasys will now be able to receive the drug …
Patients use NICE to challenge doctors
December 4, 2008Sales and Marketing NICE
Patients are increasingly holding doctors to account by bringing NICE guidance with them to consultations. Debate at NICE's annual conference …
Pharma could be top performer in recession, says AZ chief
December 4, 2008Sales and Marketing AZ, hc
AstraZeneca's chief executive David Brennan says the pharmaceutical industry could be one of the top performing sectors during the global …
Industry hits back at Commission probe
December 4, 2008Sales and Marketing Europe, reform
The pharmaceutical industry has hit back at what it says is an ill-informed attack on the sector by the European …
Boehringer to switch Flomax from POM to P
December 3, 2008Sales and Marketing OTC
Boehringer Ingelheim's consumer arm has applied to make its urological disorder drug Flomax (tamsulosin) available in the UK from pharmacists …
Cancer deaths in England down
December 3, 2008Sales and Marketing NHS
Cancer death rates in England have dropped and one-year survival rates are up, according to the Department of Health. But …
MedImmune’s respiratory treatment faces US approval delay
December 3, 2008Sales and Marketing US, reg, resp
One of MedImmune's key products has hit a delay in the US, after regulators demanded further data. The FDA asked …
Not a ‘polyclinic’: Johnson opens the first GP-led health centre
December 3, 2008NHS, reform
The first of a new generation of primary care centres has been opened in Bradford, which the government hopes will …
Effective marketing training
December 3, 2008Business Services careers, training
When the UK's Olympics team came home from Beijing this summer, laden with a record haul of medals, the nation …
Hope for Obama’s healthcare IT plan
December 1, 2008Sales and Marketing US, hc, reform
The election of Barack Obama has brought high expectations, with his "Change Can Happen" mantra signaling to many that a …
Daiichi Sankyo sets up Ireland operations
November 27, 2008Sales and Marketing Daiichi, Ireland
Japanese company Daiichi Sankyo is continuing its expansion in Europe with the launch of operations in Ireland.The new subsidiary's headquarters …
Commission to reveal anti-competitive probe findings
November 27, 2008Sales and Marketing EU, reg
The European pharmaceutical industry could shortly face a major inquiry into its practices, with the European Commission ready to reveal …
Grunenthal’s new pain treatment approved in US
November 27, 2008Sales and Marketing Grunenthal
The first new oral centrally acting analgesic in more than 25 years has been approved in the US.Tapentadol was developed …
BMS breast cancer drug rejected
November 27, 2008Sales and Marketing BMS, Cancer, breast cancer
Bristol-Myers Squibb's breast cancer drug Ixempra has suffered a setback in the EU over safety concerns.The Committee for Medicinal Products …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
